These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8478017)

  • 1. Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction.
    Friedlander Y; Dann EJ; Leitersdorf E
    Hum Genet; 1993 Apr; 91(3):299-300. PubMed ID: 8478017
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Benlian P; de Gennes JL; Dairou F; Hermelin B; Ginon I; Villain E; Lagarde JP; Federspiel MC; Bertrand V; Bernard C; Bereziat G
    Hum Mutat; 1996; 7(4):340-5. PubMed ID: 8723684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a heterozygous compound individual with familial hypercholesterolemia and familial defective apolipoprotein B-100.
    Rauh G; Schuster H; Fischer J; Keller C; Wolfram G; Zöllner N
    Klin Wochenschr; 1991 May; 69(7):320-4. PubMed ID: 2067318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
    Innerarity TL; Mahley RW; Weisgraber KH; Bersot TP; Krauss RM; Vega GL; Grundy SM; Friedl W; Davignon J; McCarthy BJ
    J Lipid Res; 1990 Aug; 31(8):1337-49. PubMed ID: 2280177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia.
    Nohara A; Yagi K; Inazu A; Kajinami K; Koizumi J; Mabuchi H
    Lancet; 1995 Jun; 345(8962):1438. PubMed ID: 7760626
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia.
    O'Malley JP; Maslen CL; Illingworth DR
    Circulation; 1998 May; 97(18):1780-3. PubMed ID: 9603531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolaemia due to familial defective apolipoprotein B-100 in two Australian families.
    Hosking JL; Bais R; Roach PD; Thomas DW
    Med J Aust; 1991 Oct; 155(8):572-3. PubMed ID: 1943942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Absence of DNA polymorphisms on the region of the APOV gene coding the proposed low density lipoprotein-binding domain of the ApoB-100 protein].
    Shevtsov SP
    Genetika; 1996 Feb; 32(2):295-7. PubMed ID: 8713626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
    Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
    Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intima-media thickness and atherosclerotic plaques in familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Kaiser M; Temelkova-Kurktschiev T; Hanefeld M
    Ann N Y Acad Sci; 2002 Jun; 967():528-34. PubMed ID: 12079884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of familial hypercholesterolemia.
    Chan L
    Beitr Infusionsther; 1988; 23():8-17. PubMed ID: 2484785
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease.
    Tybjaerg-Hansen A; Humphries SE
    Atherosclerosis; 1992 Oct; 96(2-3):91-107. PubMed ID: 1466657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?
    Miserez AR; Muller PY
    Atherosclerosis; 2000 Feb; 148(2):433-6. PubMed ID: 10657582
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypercholesterolaemia presenting in a patient with familial defective apolipoprotein B-100 and hypothyroidism.
    Wenham PR; Giles PD; Ashby JP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():221-5. PubMed ID: 7785956
    [No Abstract]   [Full Text] [Related]  

  • 17. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES; Koay ES; Chan E; Seng TJ; Loh LM; Sethi SK; Tan CE
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du Myocarde.
    Brousseau T; Arveiler D; Cambou JP; Evans AE; Luc G; Fruchart JC; Cambien F; Amouyel P
    Atherosclerosis; 1995 Aug; 116(2):269-71. PubMed ID: 7575782
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in the apolipoprotein B-100 gene: an important underlying cause of familially transmitted hypercholesterolemia and premature arteriosclerosis?
    Chan L
    Am J Cardiol; 1989 Mar; 63(11):740-2. PubMed ID: 2923061
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial defective apolipoprotein B-100: molecular basis, prevalence and clinical features.
    Friedl W
    Wien Klin Wochenschr; 1991; 103(20):621-5. PubMed ID: 1763509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.